LiveZilla Live Chat Software
Venta Casona de 1970 en Cantabria

04/10/2010 MAGNETECS, ADJUDICA A BURCONS LA IMPLANTACIÓN DEL PRIMER CENTRO EN EL MUNDO DE SALA ROBOTIZADA PARA CATETERISMOS.

04/10/2010 magnetecs, Adjudica A burcons la implantación del primer centro en el mundo de sala robotizada para cateterismos.

La Paz, primer centro del mundo con una sala robotizada para cateterismos [Spanish]

October 04, 2010


BURCONS-MAGNETECS-Esperanza Aguirre-José Luis Merino

 

Entre gallegos anda el juego. Es sorprendente la excelente impronta que está dejando en el Hospital La Paz el ilustre gallego Rafael Santamarina. Une a su discreta forma de actuar su eficacia comprobada. Le siguen entre otros muchos departamentos de ese centro, el que dirige el cualificado y referenciadelas publicaciones internacionales en Cardiología, el doctor José Luis López-Sendón, que se acompaña por un gran equipo entre los que destacan los doctores Eduardo López de Sá, José Luis Merino y el intervensionista Raúl Moreno.


El Hospital madrileño La Paz se ha convertido en el primero del mundo en contar con una sala robotizada para realizar cateterismos.


El hospital madrileño La Paz se ha convertido en el primero del mundo en contar con una sala robotizada para realizar cateterismos gracias al convenio suscrito entre el instituto de investigación del propio hospital, el Idipaz, y la compañía americana Magnetecs Corporation por el que el centro español ofrecerá las instalaciones y los profesionales,mientras que la empresa invertirá cinco millones de dólares en la tecnología.

 

El nuevo equipo, denominado Sistema de Control Guiado y de Imagen de Catéteres, permite manejar el catéter dentro del cuerpo gracias a un campo magnético en lugar del empuje mecánico de los sistemas tradicionales. Cuenta con ocho bobinas eléctricas, que actúan de electroimanes y están situadas alrededor del torso del paciente. Estas bobinas generan un potente campo magnético focalizado sobre el corazón, que moviliza la punta de un catéter especial.

 

El campo magnético se puede cambiar de forma prácticamente instantánea con sólo modificar la cantidad de corriente que pasa por cada bobina, de forma que se puede ir dirigiendo al catéter en tiempo real e incluso fijarlo de forma estable en un determinado punto del corazón.


Pionero en arritmias 
La presidenta de la Comunidad de Madrid, Esperanza Aguirre, que inauguró las instalaciones, subrayó que el Servicio de Cardiología de La Paz es pionero en España en el tratamiento de arritmias complejas, cardiopatías congénitas y otras enfermedades cardiacas. En su área de adultos se realizan cada año más de 400 intervenciones terapéuticas en pacientes con arritmias.


Medicina robotizada 
Además,anunció que en un futuro “no muy lejano” se espera que se constituya en el centro madrileño un centro Internacional de Medicina robotizada centrando en las investigaciones en otros campos, no solamente en la Cardiología, sino también en otros ámbitos como la Gastroenterología o las Neurociencias.

 

 

http://www.magnetecs.com/news.php?id=35

President of Madrid Inaugerates Magnetecs EP Lab in Spain

October 04, 2010


BURCONS-MAGNETECS

 

Doña Esperanza Aguirre y Gil de Biedma, Countess of Murillo, Grandee of Spain, and the current President of Madrid, with Josh Shachar, CEO and CTO of Magnetecs Corporation at opening of Magnetecs EP lab in Hospital General Universitario La Paz.

Inglewood, CA – Magnetecs Corporation, a designer and manufacturer of robotic systems for minimally invasive surgical procedures, today reported the inauguration of the electrophysiology lab at Hospital General Universitario La Paz in Madrid, Spain, equipped with the Company’s CGCI Catheter Guidance Control and Imaging (CGCI) system.

 

The opening ceremonies included a keynote address by Doña Esperanza Aguirre y Gil de Biedma, Countess of Murillo, Grandee of Spain, who is President of Madrid, President of Madrid's People's Party and the first female politician in Spain to have held the offices of President of the Senate and Minister of Education and Culture. “We are proud that La Paz hospital is the first in the world to have this advanced system for treating heart conditions,” said President Aguirre. “The cardiology department of La Paz Hospital is a pioneer in the treatment of complex arrhythmias and other diseases of the heart. This new electrophysiology laboratory is an important milestone in the research and treatment of heart disease.”

 

With President Aguirre at the inauguration of the electrophysiology laboratory was Javier Fernandez-Lasquetty, Minister of Health. In addition to dignitaries from Spain the ceremonies were conducted by Dr. Jose Merino, Director of the Arrhythmia & Electrophysiology Research Unit of the hospital, and Josh Shachar, Chief Executive Officer and Chief Technology Officer of Magnetecs Corporation.

 

Human studies of the CGCI system are scheduled to begin on October 7, 2010. The Principal Investigator for the studies is Dr. Vivek Reddy, Professor of Medicine and Director, Cardiac Arrhythmia Service, Mount Sinai School of Medicine, in New York City. The studies will also be conducted by Dr. Eli Gang, Chief Medical Officer of Magnetecs, Clinical Professor of Medicine, Geffen School of Medicine at UCLA, and has served as Director of the Clinical Electrophysiology Laboratory at Cedars-Sinai Medical Center in Los Angeles.

 

The initial study will consist of 20 patients in which a highly detailed map of the heart will be created using the CGCI magnetically guided catheter. The mapping study is expected to be completed by the end of 2010, and will be followed by a study of 40 patients in which mapping and ablation procedures will be conducted using the CGCI system. The second study is expected to be completed in the second quarter of 2011.

 

BURCONS-MAGNETECS-Esperanza Aguirre-Josh Shachar-José Luis Merino

 

Dr. Merino and Team at CGCI Control Console

 

BURCONS-MAGNETECS-Sala Robotizada Cateterismos

 

CGCI EP Suite at La Paz Hospital in Madrid

CGCI HUMAN TRIALS IN MADRID FOR CE MARK CERTIFICATION 
CGCI uses eight electromagnets in a unique configuration to intelligently guide a magnetically-tipped catheter, enabling a physician to precisely and consistently control surgical tools in highly dynamic or previously inaccessible environments while enhancing both the physician’s dexterity and the patient’s safety. The first study in mapping of the heart is a diagnostic procedure that is performed for patients who have arrhythmia, or irregular heart beat. Magnetecs expects this study to lead to a CE Mark application for commercialization in Europe planned for the first half of 2011. Additional human studies for ablation are expected to lead to approval of the CGCI system for therapeutic procedures used to correct heart arrhythmia.

 

PLANNED CGCI INSTALLATIONS IN LONDON, NEW YORK CITY AND PRAGUE 
Additional installations in Europe and the US will support the Company's program to receive FDA 510(k) certification. Magnetecs is currently in the initial stages of planning human studies in the US at Mount Sinai Medical Center in New York City under the direction of Dr. Reddy and Dr. Andre d'Avila, and in the UK at St. Mary’s Hospital in London under the direction of Dr. Nicholas Peters and Dr. Wyn Davies. CGCI installations and studies are also currently being planned at Na Homolce Hospital in Prague, Czech Republic, and at Cedars-Sinai Medical Center in Los Angeles, California.

 

MAGNETECS

ABOUT CGCI 
CGCI provides a unified system for robotic guidance, control and imaging of electrophysiology and other procedures. The CGCI system is integrated with sophisticated cardiac mapping and navigation technologies, including intracardiac echocardiography (ICE), and other advanced electrophysiology lab technologies and equipment. Magnetecs is planning additional applications of the Company’s electromagnetic technology in the fields of interventional cardiology, gastroenterology, neurology, and gynecology.

 

ABOUT MAGNETECS 
Magnetecs Corporation designs and manufactures a unique and highly efficient robotic catheterization control system for minimally invasive surgical procedures, and the advanced specialized tools used in these procedures. The Company believes that its proprietary Catheter Guidance Control and Imaging (CGCI) system will greatly improve the efficacy, safety and cost efficiency of many common minimally invasive surgeries. Magnetecs has established advanced electrophysiology surgical suites for CGCI development and testing at the Company’s headquarters facility in Inglewood, California.

For Further Information, Contact: 
Daniel Saks, SVP, Corporate Affairs 
(310) 670-7700